Alnylam Pharmaceuticals

Moderna

Sarepta Therapeutics

Illumina

Natera

Insmed

Catalent

Vaxcyte

Roivant Sciences Ltd

Exact Sciences

Principal Healthcare Innovators Index ETF

BTEC is actively managed to hold equities of small- and mid-cap healthcare firms in the US. The fund uses a proprietary, quantitative model to construct the portfolio.

ARK Genomic Revolution Multi-Sector ETF

Global X Genomics & Biotechnology ETF

iShares Genomics Immunology and Healthcare ETF

SPDR S&P Biotech ETF

The coronavirus pandemic triggered a race to introduce vaccine and treatment, thereby opening up new investing opportunities in the biotech sector in 2020.

Top-Performing Biotech ETFs Amid the COVID-19 Crisis

Principal Spectrum Preferred Secs Active ETF

Principal U.S. Mega-Cap ETF

ETF Trends CEO Tom Lydon spoke with Ed Nini, Global Head of Product Strategy for Principal Global Investors, about the tumultuous year that has been 2020 and what kinds of strategies have been put into place with various advisors to account for it. Specifically, Lydon wanted to hear from Nini about the trends in portfolio [.

Principal on Trends in Portfolio Construction Amid 2020 Volatility

Bolstered by positioning that includes exposure to companies fighting the coronavirus pandemic, the Principal Healthcare Innovators Index ETF (BTEC) is a pleasant surprise among healthcare exchange traded funds this year. Many market observers remain bullish on the healthcare sector's prospects for 2021.

The BTEC ETF: Access to Consistent Healthcare Innovation

The Principal Healthcare Innovators Index ETF (BTEC) is often viewed as an exchange traded fund with access to biotechnology stocks and companies working on coronavirus vaccines. That's true, but the fund is levered to some other promising healthcare themes, including telemedicine.

Principal's BTEC ETF Luring Investors Seeking Telemedicine Exposure

With progress being made on the coronavirus vaccine front, the Principal Healthcare Innovators Index ETF (BTEC) is an example of a healthcare exchange traded fund getting into its groove. Fortunately, there's still growth and value to be accessed in the healthcare sector according.

ETF Opportunities Abound in an Increasingly Monolithic Healthcare Industry

The best biotech ETFs for Q1 2021 are ARKG, BTEC, and IDNA.

Best Biotech ETFs for Q1 2021

The race to bringing a coronavirus vaccine to market is heating up. That spells opportunity for the Principal Healthcare Innovators Index ETF (BTEC).

The Intensifying Vaccine Race Spells Success for BTEC

Home Depot

Financial Select Sector SPDR Fund

With the latest quarterly results season well underway, let's take a look at 3 stocks to buy for earnings announcement returns. The post 3 Stocks To Buy For Earnings Announcement Returns appeared first on InvestorPlace.

3 Stocks To Buy For Earnings Announcement Returns

The Principal Healthcare Innovators Index ETF (Nasdaq: BTEC) is an example of an exchange traded fund that's been sensitive to coronavirus vaccine headlines. While there's a lot to like about the Principal ETF from a long-term perspective, vaccine news could again emerge as a pivotal near-term factor for the fund.

The Principal Healthcare ETF Thriving under Vaccine Progress

Invesco Dynamic Biotechnology & Genome ETF

Invesco DWA Healthcare Momentum ETF

After setting scintillating paces earlier this thanks to the race to develop a coronavirus vaccine, some health care exchange-traded funds are languishing.

3 Health Care ETFs Where Components Are Enduring Downgrades

Virtus LifeSci Biotech Clinical Trials ETF

Defiance Nasdaq Junior Biotechnology ETF

Marinus Pharmaceuticals

Novus Therapeutics

Cassava Sciences Inc

Wave Life Sciences

The healthcare sector defied last week's market rout buoyed by the progress in the development of a coronavirus vaccine or treatment, and merger and acquisition news.

Healthcare ETFs, Stocks That Gained Double Digits Last Week

Roundhill Sports Betting & iGaming ETF

Global X Lithium & Battery Tech ETF

The S&P 500, the Dow Jones and the Nasdaq Composite have lost about 0.6%, 0.03% and 0.6%, respectively, past week.

4 Best-Performing Sector ETFs of Last Week

Biotechnology mergers and acquisitions appear to be back in a big way with news that Gilead Sciences (NASDAQ: GILD) is acquiring Immunomedics (NASDAQ: IMMU) for $21 billion.

3 ETFs To Play Gilead's $21B Immunomedics Takeover

Among healthcare ETFs, the Principal Healthcare Innovators Index ETF (BTEC) is one of the names taking the category by storm this year. BTEC seeks to provide investment results that closely correspond, before expenses, to the performance of the Nasdaq Healthcare Innovators Index.

Innovation Sets This Healthcare ETF Apart

VanEck Vectors Biotech ETF

Loncar Cancer Immunotherapy ETF

Amplify Treatments Testing & Advancements ETF

iShares Nasdaq Biotechnology ETF

Per the latest data from an early stage clinical trial, Moderna's experimental coronavirus vaccine is successfully producing neutralizing antibodies and T-cells in older adults.

Moderna ETFs to Gain on New Positive COVID-19 Vaccine Data

As we take a closer look at the opportunities in the biotechnology industry, investors can focus on healthcare developments posed to support rapid growth through a targeted exchange traded fund investment strategy designed to capitalize on innovation in the sector.

A Targeted Biotech ETF to Access Next-Gen Healthcare Opportunities

Small-cap biotech ETFs may prove to be winning bets with or without coronavirus.

Why Small-Cap Biotech ETFs Are Good Long-Term Bets

The Principal Healthcare Innovators Index ETF (Nasdaq: BTEC) is already on a scintillating pace this year and that upside could be extended as a wave of coronavirus vaccines hits the wires over the near-term. This batch of news is vital because many of the companies involved in the COVID-19 vaccine competition, including some BTEC member [.

Coronavirus Vaccine is Coming, Providing Catalysts for this ETF

The Principal Healthcare Innovators Index ETF (Nasdaq: BTEC) is among the cadre of healthcare ETFs that are soaring this year owing to the COVID-19 pandemic, but with Election Day drawing closer, investors should remember this sector is sensitive to political outcomes. There are never any guarantees when it comes to healthcare and politics, but BTEC’s [.

A Healthcare ETF Offering Some Immunity During Election Year

With significant tailwinds by way of the coronavirus pandemic, the Principal Healthcare Innovators Index ETF (Nasdaq: BTEC) is a rising star among healthcare ETFs. Fortunately, the long-term outlook for the Principal ETF is compelling, too, indicating it can thrive when the virus is finally defeated.

Possibilities Remain Plentiful for This Innovative ETF

Amid the coronavirus pandemic, some healthcare ETFs are coming off age and showing they have the right mix of innovation and growth to reward investors. That group includes the Principal Healthcare Innovators Index ETF (BTEC).

Bank on BTEC for Healthcare Growth

6 Best Biotech ETFs to Buy for Cutting-Edge Growth

First Trust NYSE Arca Biotechnology Index Fund

ALPS Medical Breakthroughs ETF

Biotech ETFs are popular and delivering for investors, but not all of these funds need the Covid-19 pandemic to soar.

7 Biotech ETFs to Buy Now For Covid-19 And Beyond

It’s been an eventful first seven months of 2020 for healthcare ETFs. With innovation and the coronavirus fight at the forefront of the sector discussion, the Principal Healthcare Innovators Index ETF (Nasdaq: BTEC) is emerging as a leader in a new breed of healthcare ETFs.

How to Capitalize on Healthcare Innovation

The Principal Healthcare Innovators Index ETF (Nasdaq: BTEC) is one of this year’s most impressive stories among the up-and-coming industry ETFs and the race to develop a coronavirus vaccine is a prime reason why BTEC is soaring. BTEC tracks the Nasdaq U.S.

News for Principal Healthcare Innovators Index ETF ETF (BTEC)